$1.15
3.36%
Nasdaq, Sep 25, 04:00 pm EDT. Closed.
ISIN
US57055L1070
Symbol
MRKR
Reports
Quarter | Annual
Index
NASDAQ Composite
Sector
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology

Marker Therapeutics, Inc. Stock News

Neutral
Marker Therapeutics, Inc.
●
GlobeNewsWire
●
4 days ago
Marker Therapeutics Highlights Expanded Manufacturing Support of CDMO Partner Following Formation of Kincellis Advanced Therapies
HOUSTON, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company developing multi-antigen recognizing (MAR)-T cell therapies for the treatment of hematologic malignancies and solid tumors, today highlighted the expanded infrastructure, technical expertise and manufacturing capabilities supporting its lead program, MT-601 (neldaleucel...

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now
The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today